Ivor Macleod - 17 Jun 2022 Form 4 Insider Report for ATHERSYS, INC / NEW

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
21 Jun 2022, 18:00:55 UTC
Prior SEC filing
18 Mar 2022
Next SEC filing
26 Oct 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Katherine M. Serevitch, as attorney-in-fact for Ivor Macleod

Key filing fact

Ivor Macleod filed Form 4 for ATHERSYS, INC / NEW on 21 Jun 2022.

Key facts

  • This page summarizes Ivor Macleod's Form 4 filing for ATHERSYS, INC / NEW.
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 21 Jun 2022, 18:00.

Change

  • Previous filing in this sequence was filed on 18 Mar 2022.
  • Current net transaction value: -$175.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ATHX transaction

Common Stock

Tax liability

Transaction value
$175
Shares
-624
Change %
-0.43%
Price
$0.2800
Shares after
143,290
Date
17 Jun 2022
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Shares withheld from the quarterly vesting of annual restricted stock unit awards related to the tax withholding obligation.

Footnote F2

Securities beneficially owned are comprised of (1) 43,290 shares of common stock owned and (2) unvested restricted stock units aggregating 100,000 related to annual awards, which vest quarterly over a four-year period from date of grant.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .